Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Antineutrophil cytoplasmic autoantibodies (ANCAs) are identified in the circulation of approximately 80% of patients with pauci-immune necrotizing and crescentic glomerulonephritis and systemic small vessel vasculitis, such as microscopic polyangiitis and Wegener granulomatosis. The most common antigen target for ANCAs is myeloperoxidase (MPO), which is found in neutrophils and monocytes. We report definitive experimental animal evidence that ANCAs are pathogenic. MPO knockout (Mpo(-/-)) mice were immunized with mouse MPO. Splenocytes from these mice or from control mice were injected intravenously into recombinase-activating gene-2-deficient (Rag2(-/-)) mice, which lack functioning B lymphocytes and T lymphocytes. All mice that received splenocytes developed mild to moderate glomerular immune deposits, but only mice that received 1 x 10(8) or 5 x 10(7) anti-MPO splenocytes developed severe necrotizing and crescentic glomerulonephritis, granulomatous inflammation, and systemic necrotizing vasculitis, including necrotizing arteritis and hemorrhagic pulmonary capillaritis. To test the pathogenic potential of antibodies alone, purified anti-MPO IgG or control IgG was injected intravenously into Rag2(-/-) mice and wild-type mice. Mice that received anti-MPO IgG but not mice that received control IgG developed focal necrotizing and crescentic glomerulonephritis with a paucity of glomerular Ig deposition. Thus, anti-MPO IgG alone was able to cause pauci-immune glomerular necrosis and crescent formation in the absence of functional T or B lymphocytes in Rag2(-/-) mice and in the presence of an intact immune system in wild-type C57BL/6J mice. This animal model offers strong support for a direct pathogenic role for ANCA IgG in human glomerulonephritis and vasculitis.

[1]  C. Savage,et al.  New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis , 2002, Current opinion in rheumatology.

[2]  D. Connolly,et al.  Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase. , 2000, Protein expression and purification.

[3]  N. Maeda,et al.  Severe Impairment in Early Host Defense againstCandida albicans in Mice Deficient in Myeloperoxidase , 1999, Infection and Immunity.

[4]  D. Adu,et al.  Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 1999, Kidney international.

[5]  R. Falk,et al.  Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  C. Kallenberg,et al.  Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. , 1998, Kidney international.

[7]  R. Falk,et al.  Small-vessel vasculitis. , 1997, The New England journal of medicine.

[8]  C. Marsh,et al.  Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. , 1997, The Journal of clinical investigation.

[9]  R. Dinkel,et al.  The effects of dementia in German acute care hospitals. , 1997, Dementia and geriatric cognitive disorders.

[10]  R. Falk,et al.  ANCA small-vessel vasculitis. , 1997, Journal of the American Society of Nephrology : JASN.

[11]  D. Adu,et al.  IL‐1β production by human polymorphonuclear leucocytes stimulated by anti‐neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis , 1996, Clinical and experimental immunology.

[12]  W. Seeger,et al.  Neutrophi l Act ivat ion by Ant i-Prote inase 3 Ant ibod ies in Wegener ' s Granulomatos , 2003 .

[13]  J. Warren,et al.  Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. , 1995, The Journal of laboratory and clinical medicine.

[14]  C. Kallenberg,et al.  Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. , 1994, Kidney international.

[15]  J. Pearson,et al.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. , 1992, The American journal of pathology.

[16]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[17]  R. Falk,et al.  Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. , 1992, Kidney international.

[18]  R. Falk,et al.  Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes , 1992, Journal of leukocyte biology.

[19]  R. Terrell,et al.  Antibodies Against Granule Proteins Activate Neutrophils In Vitro , 1991, Journal of leukocyte biology.

[20]  R J Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Hoidal,et al.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.

[22]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[23]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.